Investors

Key figures

Key figures

(EUR million)

2023 2022 2021 2020 2019
Net sales 24.7 21.6 17.8 14.9 13.8
SaaS (subscription licenses1) 16.8 13.8 10.9 8.8 7.1
Perpetual licenses (licenses1) 0.0 0.0 0.0 0.1 0.2
Maintenance (support and maintenance1) 0.8 0.9 1.0 1.0 1.3
Services 7.0 6.9 5.8 4.9 5.3
International (% of net sales) 24% 25% 25.% 24% 19%
Recurring revenue (% of net sales) 71% 68% 67% 66% 61%
Net sales growth (%) 14.3% 21.6% 19.3% 7.6% 11%
EBITDA3 0.2 0.0% 0.9 0.1 -1.0
EBITDA %3 0.7% 0.1% 5.3% 0.8% -7.2%
Operating profit before amortization of goodwill (EBITA),3 -0.6 0.6 0.5 -0.3 -1.4
Operating profit before amortization of goodwill (EBITA), %3 -2.5% -2.7% 2.5% -2.1% -9.9%
Operating profit (EBIT) -1.2 -0.9 0.4 -0.3 -1.4
Operating profit (EBIT), % -4.9% -4.0% -2.2% -10.1%
Earnings for the period -1.3 0.3 0.4 -0.3 -1.4
Equity ratio, %3 31% 39% 46% 35% 42%
Net gearing, %3 -16% -28% 197% 270% 159%
Number of employees at the end of the period 199 194 125 106 107
Number of shares at the end of the period 6,446,542 6,372,157 6,219,469 6,056,623 5,957,488

Key figure formulas add

Key figure Formula
EBITDA = Operating profit + depreciation and amortization
EBITDA margin % = EBITDA / Net sales x 100
EBITA = Operating profit + amortization of goodwill
EBITA % = EBITA / Liikevaihto x100
EBITA margin % = EBITA / Net sales x100
Operating profit % = Operating profit / Net sales x100
Net interest-bearing debt = Interest-bearing debt – cash in hand and at banks – financial securities
Net gearing % = Net interest-bearing debt / Shareholders’ equity x100
Equity ratio % = Shareholders’ equity / Balance sheet total – advances received x100
Return on equity (ROE) % = Profit/loss before taxes for the period + financial expenses / Shareholders’ equity + interest-bearing financial liabilities (annualized, on average) (interim figure has been calculated by adjusting the interim period’s earnings to reflect 12 months and by using the average value of shareholders’ equities for the interim period) x100
Research and product development costs, % of net sales = Research and product development costs / Net sales x100
Earnings per share (EPS) = Profit/loss for the period / Average number of shares outstanding during the period
Shareholders’ equity per share = Shareholders’ equity / Number of shares outstanding, undiluted on the balance sheet date
Recurring revenue = SaaS and maintenance net sales